Table 2.
Path | b | CI Lower | CI Upper | SE | β | ||
---|---|---|---|---|---|---|---|
D-score NEG | → | Vaccination | 0.05 | −0.06 | 0.19 | 0.07 | 0.05 |
D-score POS | → | Vaccination | 0.21 ** | 0.06 | 0.35 | 0.07 | 0.20 |
D-score NEG | → | Explicit prop. | 0.72 ** | 0.21 | 1.21 | 0.26 | 0.24 |
D-score POS | → | Explicit prop. | −0.21 | −0.80 | 0.44 | 0.32 | −0.06 |
Explicit prop. | → | Vaccination | 0.09 ** | 0.05 | 0.15 | 0.03 | 0.29 |
Indirect effect of D-score POS | 0.07 * | 0.02 | 0.15 | 0.03 | 0.07 | ||
Indirect effect of D-score NEG | −0.02 | −0.09 | 0.03 | 0.03 | −0.02 | ||
Total effect | 0.31 ** | 0.09 | 0.50 | 0.11 | 0.30 |
Note. b = unstandardized coefficient, CI lower and CI upper = lower and upper 95% bootstrapped confidence intervals of b, SE = standard error, β = standardized coefficient. D-score POS = D-scores for VACCINE-positive trials; D-score NEG = D-scores for VACCINE-negative trials. The significant level is indicated as follows: * p < 0.05, ** p < 0.01.